Products Archive - Euroimmun Blog

Serological diagnostics of Oropouche virus infections: Euroimmun Brazil launches new ANVISA-approved ELISAs

Dr. Rebekka Witte — Thu, 19 Feb 2026 10:53:32 +0000

Climate change, population growth, global travel and shifting lifestyles all increase both how likely and how quickly infectious diseases spread. This is especially true for arboviruses, which are vector-borne and include dengue virus, chikungunya virus and Oropouche virus. Oropouche fever in Brazil Brazil is a powerful example: Since the end of 2023, the incidence of […]

Der Beitrag Serological diagnostics of Oropouche virus infections: Euroimmun Brazil launches new ANVISA-approved ELISAs erschien zuerst auf Euroimmun Blog.

Euroimmun sets new standards in serological neurological diagnostics

Dr. Swantje Seifert — Mon, 02 Feb 2026 08:40:51 +0000

Long anticipated – now available: the neurology portfolio for the UNIQO 160, our all-in-one automated IFA system, has been expanded by nine more indirect immunofluorescence assays (IFA). While the previous portfolio primarily contained classic Euroimmun BIOCHIP Mosaics with different tissue sections as substrates, these new additions are highly relevant monospecific IFA with a particular focus […]

Der Beitrag Euroimmun sets new standards in serological neurological diagnostics erschien zuerst auf Euroimmun Blog.

New addition to our dengue test portfolio: Highest specificity for your diagnostics.

Dr. Konstanze Stiba — Thu, 27 Nov 2025 12:02:03 +0000

Currently, dengue fever poses the greatest challenge in terms of arbovirus infections. With over 14 million cases reported worldwide in 2024, this is the largest ever recorded epidemic of vector-borne viral diseases [1]. In Europe, 304 autochthonous cases were registered in the same year, representing a significant increase compared to 130 cases in 2023 and […]

Der Beitrag New addition to our dengue test portfolio: Highest specificity for your diagnostics. erschien zuerst auf Euroimmun Blog.

Circulating calprotectin – a new promising inflammation parameter

Dr. Anne Rupprecht — Wed, 26 Nov 2025 13:16:00 +0000

With passion for rheumatology! The evaluation of the inflammatory status is crucial for the assessment of disease activity and therapy response in systemic autoimmune rheumatic diseases such as rheumatoid arthritis, systemic sclerosis, psoriasis arthritis or microscopic polyangiitis. A promising new biomarker in this context is the increasingly important inflammation parameter circulating calprotectin (cCALP). Calprotectin in […]

Der Beitrag Circulating calprotectin – a new promising inflammation parameter erschien zuerst auf Euroimmun Blog.

Arboviruses: global threat and local reality

Dr. Konstanze Stiba — Thu, 16 Oct 2025 10:07:19 +0000

Vector-borne diseases such as dengue, chikungunya, Zika and West Nile fever account for more than 17% of all infectious diseases worldwide [1]. According to the World Health Organization (WHO), over 5.6 billion people live in areas at risk of arboviral infections – that’s more than half of the global population [2]. With over 35 years […]

Der Beitrag Arboviruses: global threat and local reality erschien zuerst auf Euroimmun Blog.